DekaBank Deutsche Girozentrale’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,250
| Closed | -$1.63M | – | 1432 |
|
|
2022
Q3 | $1.63M | Hold |
24,250
| – | – | ﹤0.01% | 751 |
|
|
2022
Q2 | $768K | Hold |
24,250
| – | – | ﹤0.01% | 935 |
|
|
2022
Q1 | $848K | Buy |
24,250
+2,200
| +10% | +$65.8K | ﹤0.01% | 943 |
|
|
2021
Q4 | $659K | Buy |
22,050
+600
| +3% | +$18.6K | ﹤0.01% | 1035 |
|
|
2021
Q3 | $548K | Hold |
21,450
| – | – | ﹤0.01% | 1029 |
|
|
2021
Q2 | $686K | Hold |
21,450
| – | – | ﹤0.01% | 994 |
|
|
2021
Q1 | $864K | Hold |
21,450
| – | – | ﹤0.01% | 933 |
|
|
2020
Q4 | $938K | Sell |
21,450
-1,100
| -5% | -$54.2K | ﹤0.01% | 884 |
|
|
2020
Q3 | $1.2M | Buy |
+22,550
| New | +$1.43M | 0.01% | 711 |
|
|
2019
Q3 | – | Sell |
-28,600
| Closed | -$1.54M | – | 1156 |
|
|
2019
Q2 | $1.54M | Buy |
28,600
+11,100
| +63% | +$638K | 0.01% | 690 |
|
|
2019
Q1 | $858K | Buy |
17,500
+3,200
| +22% | +$157K | 0.01% | 807 |
|
|
2018
Q4 | $571K | Sell |
14,300
-3,200
| -18% | -$120K | ﹤0.01% | 807 |
|
|
2018
Q3 | $858K | Sell |
17,500
-500
| -3% | -$22.1K | 0.01% | 824 |
|
|
2018
Q2 | $854K | Hold |
18,000
| – | – | 0.01% | 783 |
|
|
2018
Q1 | $859K | Buy |
18,000
+10,600
| +143% | +$591K | 0.01% | 753 |
|
|
2017
Q4 | $212K | Hold |
7,400
| – | – | ﹤0.01% | 933 |
|
|
2017
Q3 | $212K | Hold |
7,400
| – | – | ﹤0.01% | 939 |
|
|
2017
Q2 | $211K | Buy |
+7,400
| New | +$220K | ﹤0.01% | 928 |
|
Other funds holding GBT
DekaBank Deutsche Girozentrale's GBT Position: Q4 2022 in Review
DekaBank Deutsche Girozentrale sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 24,250 shares — an estimated $1.63M sold.
DekaBank Deutsche Girozentrale first reported a position in GBT in Q2 2017 and held it in 18 quarters. The position peaked at $1.63M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- DekaBank Deutsche Girozentrale reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 24,250 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.63M.
- DekaBank Deutsche Girozentrale first reported a position in Global Blood Therapeutics, Inc. in Q2 2017 and held it in 18 quarters.
- DekaBank Deutsche Girozentrale's Global Blood Therapeutics, Inc. position peaked at $1.63M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.